European regulator approves use of Moderna Covid vaccine in the EU

Volunteers prepared a dose of Moderna COVID-19 vaccine on December 30, 2020 in Forand Manor, Central Falls, RI.

Boston Globe | Boston Globe | Getty Images

LONDON – The European Medicines Agency On Wednesday, it proposed the Moderna coronavirus vaccine for use in the European Union, at a time when criticism is growing for the slow introduction of blocks.

“The EMA’s Committee for Medicinal Products for Human Use has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and has unanimously recommended that the European Commission grant a formal, conditional marketing authorization,” the EMA said in a statement.

Emer Cooke, executive director of the EMA in Amsterdam, added that vaccinating Moderna “is another tool for us to overcome the current emergency.” It paves the way for the European Commission, the EU’s executive body, to follow suit and authorize emergency use later on Wednesday.

The vaccination of Moderna is the second that has been lit green by European regulators. Some legislators have expressed concern that the EU is distributing coronavirus vaccines among citizens too slowly.

The installation of Covid-19 jabs varies from block to block. France reported 516 vaccinations in the first week of its introduction, while Germany delivered about 240,000 vaccinations by Sunday. The Netherlands has only just begun vaccinating people against the coronavirus.

There are also questions about whether the EU has bought enough vaccines.

Several officials asked the committee to explain why it did not buy more punches. A spokesman on Monday said the institution was “very focused on ensuring that our strategy was implemented, going well.”

Shares of Moderna rose slightly in pre-market trading against the background of the announcement.